Co-Stimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: A Randomised, Double-Blind, Placebo-Controlled Trial

Study Questions:

Does modulation of T-cell activation with abatacept in patients with type 1 diabetes mellitus (DM) lead to preservation of pancreatic β-cell function?